[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]
- PMID: 17313874
[A follow up study of total IgM, IgG, nucleoprotein and spike protein antibodies against severe acute respiratory syndrome (SARS) coronavirus in patients with SARS]
Abstract
Objective: To survey the dynamic changing and persistence of the special antibodies, including total IgM, IgG, nucleocapsid protein and spike protein antibodies, against severe acute respiratory syndrome coronavirus (SARS-CoV) in patients with SARS.
Methods: 146 cases, all clinically diagnosed as SARS with positive SARS-CoV IgG, were followed up. 362 serum samples were collected from the onset of the disease to 660 days afterward. Total IgM and IgG against SARS-CoV were tested with commercial ELISA kits. For recombinant nucleoprotein and spike protein, we developed an ELISA to test these two antibodies.
Results: Within 20 days of the onset, the positive rate of anti-SARS-CoV IgM was 46.5% (20/43); it reached a peak after 21 - 40 days (80.6%, 25/31). Then, the positive rate of IgM went down gradually to 8.2% (6/73) until 550 days after the onset. The patient's IgG positive rate was lower (34.9%, 15/43) than that of IgM within 20 days of the onset. Then it went up rapidly to 100%. It remained positive (98.6%, 70/71) until 600 - 660 days after the onset. When N-IgG and S-IgG were tested 40 days after the onset of the disease at three different times, the positive rate of N-IgG (92.5%, 37/40) was higher than that of S-IgG (67.5%, 27/40), but the two structure protein antibodies were always lower than the total IgG.
Conclusions: In SARS patients with definite clinical and etiological diagnosis, the highest positive rate of the antibodies against SARS-CoV was found at 21 - 40 days after the onset. IgM disappeared almost 500 days (91.8%) after the onset. Total IgG positive rate could reach 100% and 98.6% and the positivity might persist nearly two years. So it is speculated that the total IgG antibody may be positive 3 to 5 years after infection, but it seems that N-IgG and S-IgG keep positive shorter in time than total IgG antibody.
Similar articles
-
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004. Clin Diagn Lab Immunol. 2004. PMID: 15242938 Free PMC article.
-
[Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome].Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Jul;31(7):795-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2010. PMID: 21162846 Chinese.
-
[Specific antibodies against the nucleocapsid protein and S1 domain of spike glycoprotein in patients with severe acute respiratory syndrome].Zhonghua Yi Xue Za Zhi. 2005 Mar 2;85(8):526-9. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15949331 Chinese.
-
SARS Immunity and Vaccination.Cell Mol Immunol. 2004 Jun;1(3):193-8. Cell Mol Immunol. 2004. PMID: 16219167 Review.
-
Immunological responses against SARS-coronavirus infection in humans.Cell Mol Immunol. 2004 Apr;1(2):119-22. Cell Mol Immunol. 2004. PMID: 16212898 Review.
Cited by
-
Assessment of Long-Term Effects on Pulmonary Functions Between Severe and Non-Severe Convalescent COVID-19 Patients: A Single-Center Study in China.J Inflamm Res. 2022 Aug 19;15:4751-4761. doi: 10.2147/JIR.S371283. eCollection 2022. J Inflamm Res. 2022. PMID: 36017172 Free PMC article.
-
Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points.J Med Virol. 2025 Jan;97(1):e70161. doi: 10.1002/jmv.70161. J Med Virol. 2025. PMID: 39780477 Free PMC article.
-
Pre-vaccination immune response to COVID-19 in a population in Northeast Portugal.Ir J Med Sci. 2022 Oct;191(5):1951-1958. doi: 10.1007/s11845-021-02799-6. Epub 2021 Oct 12. Ir J Med Sci. 2022. PMID: 34642902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous